Name: Latest research reports of Abbott India Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: Sharekhan

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

29641.1000 533.05 (1.83%)

NSE Apr 11, 2025 15:31 PM

Volume: 5,580

Abbott India Ltd.

08 Aug 2024

29641.10

1.83%

Healthy earnings: growth momentum to continue

Buy: Abbott India Ltd.

Target

Sharekhan

Earnings were in line with our estimates, where sales grew by 5% y-o-y to Rs 1,557 crore (1.6% below our estimates), EBITDA grew by 10% y-o-y to Rs 3,910 crore.

Abbott India Ltd. is trading above its 200 day SMA of 28697.0